Caisse de Depot et Placement du Quebec (CDPQ)
ESPR

Caisse de Depot et Placement du Quebec (CDPQ)’s Esperion Therapeutics ESPR Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-250,000
Closed -$18.1M – 786
2018
Q1 		$18.1M Hold
250,000
– – 0.04% 189
2017
Q4 		$16.5M Hold
250,000
– – 0.04% 197
2017
Q3 		$12.6M Buy
+250,000
New +$12.1M 0.03% 220

Other funds holding ESPR

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s ESPR Position: Q2 2018 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Esperion Therapeutics (ESPR) in Q2 2018, closing a stake of 250,000 shares — an estimated $18.1M sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in ESPR in Q3 2017 and held it in 3 quarters. The position peaked at $18.1M in Q1 2018. 156 funds tracked by Wall St. Rank hold ESPR as of Q2 2018.

  • Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Esperion Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Caisse de Depot et Placement du Quebec (CDPQ) sold 250,000 Esperion Therapeutics shares in Q2 2018, an estimated $18.1M.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Esperion Therapeutics in Q3 2017 and held it in 3 quarters.
  • Caisse de Depot et Placement du Quebec (CDPQ)'s Esperion Therapeutics position peaked at $18.1M in Q1 2018.
  • 156 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2018.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2018, filed 13 Aug 2018.